-
公开(公告)号:US20240351996A1
公开(公告)日:2024-10-24
申请号:US18577851
申请日:2022-07-11
IPC分类号: C07D401/12 , A61K31/444 , A61K31/506 , C07D213/74 , C07D239/42 , C07D239/48 , C07D401/06 , C07D401/14 , C07D405/14
CPC分类号: C07D401/12 , A61K31/444 , A61K31/506 , C07D213/74 , C07D239/42 , C07D239/48 , C07D401/06 , C07D401/14 , C07D405/14
摘要: Provided herein are compounds, tautomers, or pharmaceutically acceptable salts thereof, having a structure of formula (I): wherein X1, Y, Z1, Z2, (R1)n, (R2)m, and ring A are as described herein. Also provided are pharmaceutical compositions comprising compounds, tautomers, or pharmaceutically acceptable salts having a structure of formula (I). Further provided are a method of inhibiting cyclin dependent kinase 19 (CDK19) a method of treating breast cancer with the disclosed compounds.